TREND Community Releases New Fabry Disease Community Voice Report (CVR)
Fabry disease is a rare genetic disorder caused by decreased activity of a lysosomal enzyme called alpha-galactosidase A, the enzyme that metabolizes a type of fat, primarily globotriaosylceramide (GL3).
This reduced activity leads to a buildup of GL3, which can cause cell dysfunction that can manifest in various ways, including pain and life-threatening complications such as progressive kidney damage and cardiovascular disease.
TREND analyzed the Facebook group, “Fabry's Disease Info and Support.” This overview looks at activity from July 5, 2007, until May 21, 2021.
Read the CVR here.